The risks for the transition from GDM to T2DM ranges between 3% and 70%; however the likelihood rises with women giving birth after the age of 30, birth weight of babies delivered being greater than 3.5 kg and undergoing insulin treatments throughout the gestational period [19,22]. This evidence concerns the gene INS and gestational diabetes.